
Heparinase I
Get Latest Price
In Stock
Product Specifications
| Activity | 1000 U/mg |
| CAS Number | 9025-39-2 |
| EC Number | 4.2.2.7 |
| Features | Heparin removal, Research reagent, Diagnostic testing, High purity, Precise cleavage |
| MDL Number | MFCD00131317 |
| Purity | >95% |
| Source | Flavobacterium heparinum |
| Storage | -20°C |
Product Overview
Key Features
Heparinase I (heparin lyase I) cleaves heparin and to a lesser extent heparan sulfate (ratio approx. 3:1).
Usage
Neutralization of heparin in blood and plasma samples before analysis (as an additive to or contained in collection tubes).
As a component of in vitro diagnostic tests for clotting evaluations and platelet function tests for removal of heparin interference.
Preparation of low molecular weight heparins from unfractionated heparin.
Research reagent (glycobiology, preparation of oligosaccharide libraries, preparation of dissaccharides from heparin).
General Information
Synonymsi Heparinase; heparin lyase I; heparin eliminase
Gene Source: Native Flavobacterium heparinum
EC Number: 4.2.2.7
CAS Number: 9025-39-2
MDL Number: MFCD00131317
Company Details
Beijing Adhoc International Technologies Co., Ltd is listed in Trade India's list of verified sellers offering supreme quality of Activated Factor X (FXa), Alpha-Thrombin, Antithrombin, etc. Buy Cancer, TB & Tumor Drugs in bulk from us for the best quality products and service.
Business Type
Exporter, Supplier, Trading Company
Establishment
2009
Working Days
To
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
Beijing, Beijing
Name
Mr Natalie Cho
Address
No. 63, Maquanying Fourth Zone, Chaoyang District, Beijing, Beijing, 100102, China
anticancer drugs in Beijing
Report incorrect details



























